Badanie nad bezpieczeństwem itepekimabu u pacjentów z przewlekłą obturacyjną chorobą płuc (POChP)

Chronic Obstructive Pulmonary Disease, commonly known as COPD, is a long-term lung disease that makes it hard to breathe. This study is focused on understanding the long-term safety and how well patients tolerate a medication called itepekimab. Itepekimab is given as an injection and is being tested in patients who have moderate to severe COPD. The study involves patients who have already participated in earlier studies with itepekimab.

The main goal of this study is to see if itepekimab is safe to use over a longer period. Participants will receive either itepekimab or a placebo, which looks like the medication but does not contain the active substance. The study will monitor any side effects that occur during the treatment. It will also look at how often patients experience worsening of their COPD symptoms and how the medication affects their overall health and lung function.

This study will last for about a year, and during this time, participants will have regular check-ups to assess their health and any changes in their condition. The information gathered will help determine if itepekimab is a safe and effective treatment option for people with COPD.